Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-12 22:41:31 ET
Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST...
Read the full article on Seeking Alpha
For further details see:
Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript
Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
NASDAQ: FBIOP
FBIOP Trading
-1.24% G/L:
$13.55 Last:
24,423 Volume:
$14.07 Open:
FBIOP Latest News
February 23, 2026 09:24:14 am
UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
February 23, 2026 08:30:00 am
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
January 13, 2026 07:45:00 am
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States
December 15, 2025 08:00:00 am
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
FBIOP Stock Data
$113,345,161
22,810,953
N/A
18
N/A
Biotechnology & Life Sciences
Healthcare
US
Bay Harbor Islands
